Cell and gene therapies are critical emerging treatment modalities with the potential to tackle and cure conditions from life-limiting genetic disorders to cancers. However, being novel, biological and potentially personalised presents a whole range of quality control challenges. During this conference we will address the critical element of microbiological safety and control.
Listen to leading cell and gene therapy quality control experts to discover how the industry is rapidly advancing ways to ensure microbiological QC testing can keep up with these complex therapies.
Our line-up of industry leading speakers will elaborate on the risks of inadequate microbial testing during the manufacture of cell and gene therapies, addressing how they can be mitigated to ensure patient safety. This event is for manufacturing and quality control personnel looking to:
Attend this conference to ensure that not only are your microbiological QC labs testing challenges addressed, but that your organisation is equipped with the skills, technology and guidance that it needs to release safe cell and gene therapies.
We’ve curated an exciting and topical agenda of webinars and keynote sessions for you.
Connect with all your fellow attendees and potential new partners through our dedicated online meetings platform and networking sessions. Pre-schedule or conduct instant video meetings.
Instant access to industry professions, new developments and interact in real time.
Join experts for interactive product demonstrations, Q&A’s and in depth analysis.
Join us on Wednesday 13 July 2022